Fingerprint
Dive into the research topics of 'A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
John Murren, Manuel Modiano, Shivaani Kummar, Caroline Clairmont, Merrill Egorin, Edward Chu, Mario Sznol
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations